Weekly Paclitaxel Combined with Monthly Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Thoracic Oncology

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1556-0864(15)31590-2PMID 17409879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

  2005cited by this paper
• A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index

  2005cited by this paper
• American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

  2004cited by this paper
• Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study.

  2004cited by this paper
• Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group Performance Status of 2, or age > or = 70 years.

  2004cited by this paper
• The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II study.

  2004cited by this paper
• Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy.

  2004cited by this paper
• A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.

  2004cited by this paper
• Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.

  2004cited by this paper
• Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age): A Phase II North Central Cancer Treatment Group Study

  2003cited by this paper
• Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

  2003cited by this paper
• Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.

  2003cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

  2000cited by this paper
• Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group.

  2000cited by this paper
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000cited by this paper
• Paclitaxel 175 mg/m2 plus carboplatin versus paclitaxel 225 mg/m2 plus carboplatin for advanced non small-cell lung cancer (NSCLC).

  2000cited by this paper
• Paclitaxel in advanced non-small cell lung cancer : an alternative high-dose weekly schedule.

  2000cited by this paper
• Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).

  2000cited by this paper
• Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.

  1999cited by this paper
• Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

  1997cited by this paper
• [Chemotherapy in non-small cell lung cancer].

  1997cited by this paper
• Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

  1997cited by this paper
• The National Cancer Data Base report on lung cancer

  1996cited by this paper
• Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

  1996cited by this paper
• Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

  1995cited by this paper
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.

  1995cited by this paper
• Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.

  1993cited by this paper
• Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

  1993cited by this paper
• Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS).

  1993cited by this paper
• The calculation of received dose intensity.

  1990cited by this paper
• Optimal two-stage designs for phase II clinical trials.

  1989cited by this paper

• An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer

  2019cites this paper
• CANCER THERAPY

  2018cites this paper
• Factors influencing treatment selection and survival in advanced lung cancer.

  2017cites this paper
• Novel systemic therapy in advanced non-small-cell lung cancer

  2016cites this paper
• A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer

  2015cites this paper
• Advanced non-small cell lung cancer in elderly patients: A review

  2015cites this paper
• Advanced Non-small Cell Lung Cancer in Elderly Patients: The Standard Every 3-Weeks Versus Weekly Paclitaxel With Carboplatin

  2012cites this paper
• 双药方案对比单药方案治疗老年晚期非小细胞肺癌的Meta分析

  2012cites this paper
• Chemotherapy in elderly patients with advanced non-small cell lung cancer.

  2011cites this paper
• 老年晚期非小细胞肺癌患者药物治疗现状和趋势

  2011cites this paper
• L’oncogériatrie en cancérologie thoracique : extension du domaine de la concertation

  2011cites this paper
• Weekly Paclitaxel Combined with Carboplatin Versus the Standard Every 3-Weeks Paclitaxel and Carboplatin for Elderly Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.

  2011cites this paper
• Traitement du cancer bronchique non à petites cellules métastatique chez les patients âgés: vers une évolution des pratiques

  2011cites this paper
• [Oncogeriatry in thoracic oncology: extending discussions].

  2011cites this paper
• Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

  2011cites this paper
• Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer.

  2010cites this paper
• Weekly Regimen of Paclitaxel and Carboplatin as First-Line Chemotherapy in Elderly Patients with Stage IIIB-IV Non Small Cell Lung Cancer (NSCLC): Results of a Phase II Study

  2010cites this paper
• Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

  2010cites this paper
• Low Dose Fractionated Cisplatin Plus Gemcitabine for Elderly Patients with Advanced Non Small Cell Lung Cancer: A Retrospective Analysis

  2010cites this paper
• Update on nonsmall cell lung cancer

  2010cites this paper
• Update on Impact of HRT on Breast Cancer Outcomes

  2010cites this paper
• Platinum neurotoxicity pharmacogenetics

  2009cites this paper
• A phase II study of carboplatin and paclitacel with meloxicam.

  2009cites this paper
• L’Intergroupe Francophone de Cancérologie Thoracique (IFCT) Bilan des 10 premières années

  2009cites this paper
• Dose-escalating and pharmacokinetic study of a weekly combination of paclitaxel and carboplatin for inoperable non-small cell lung cancer: JCOG 9910-DI.

  2009cites this paper
• The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.

  2009cites this paper
• Chemotherapy in advanced nonsmall cell lung cancer

  2009cites this paper
• Chimiothérapies anticancéreuses et personnes âgées : revue de la littérature Anticancer chemotherapy in the elderly: a review of the litterature

  2008cites this paper
• Patient participation in thoracic cancer clinical trials.

  2008cites this paper
• Le cancer bronchique du sujet âgé

  2008cites this paper
• quels patients âgés ? Cancers bronchopulmonaires non à petites cellules Non-small-cell lung cancer

  2008cites this paper
• [Anticancer chemotherapy in the elderly: a review of the literature].

  2008cites this paper
• [Treatment of non-small cell bronchopulmonary cancer in the elderly].

  2007cites this paper
• Traitement du cancer bronchopulmonaire non à petites cellules du sujet âgé

  2007cites this paper